Table 1. The stress-induced biomarkers identified by UPLC–MS/MS in prefrontal cortex among different groups and their change trends.
Retention (min) |
m/z |
Metabolitesa | P-valueb |
||||||
---|---|---|---|---|---|---|---|---|---|
Aqueous | Organic | Positive | Negative | CUMS versus NC | LTDE versus NC | CLO versus NC | RIS versus NC | ARI versus NC | |
0.4 | — | 103.8 | — | Choline | 0.003↑ | 0.0001↓ | ns | ns | ns |
0.5 | — | 131.8 | — | Creatine | 0.033↑ | 0.020↓ | 0.001↑ | 0.001↑ | 0.003↑ |
0.7 | — | 136.9 | — | Hypoxanthine | 0.045↓ | 0.001↑ | ns | ns | ns |
0.6 | — | — | 167.1 | Uric acid | 0.004↓ | 0.045↑ | ns | ns | ns |
0.7 | — | — | 267.1 | Inosine | 0.023↓ | 0.010↑ | 0.006↑ | ns | ns |
0.8 | — | — | 174.9 | Allantoic acid | 0.002↑ | 0.043↓ | ns | ns | ns |
9.7 | — | 496.5 | 540.5 | LysoPC(16:0) | 0.033↑ | 0.001↓ | ns | ns | ns |
10.1 | — | 522.5 | 566.5 | LysoPC(18:1) | 0.045↑ | 0.001↓ | ns | ns | ns |
10.6 | — | 524.5 | 568.5 | LysoPC(18:0) | 0.031↑ | 0.001↓ | ns | ns | ns |
— | 0.6 | 347.5 | — | Corticosterone | 0.025↑ | 0.001↓ | 0.023↓ | ns | ns |
— | 0.7 | 315.4 | — | Progesterone | 0.027↓ | 0.0001↑ | 0.023↑ | ns | ns |
— | 8.6 | — | 762.9 | PE(16:0/22:6) | 0.012↓ | 0.029↑ | 0.010↑ | 0.026↑ | ns |
— | 10.9 | — | 790.7 | PE(18:0/22:6) | 0.001↓ | 0.014↑ | 0.005↑ | ns | ns |
Abbreviations: ↓, decreased; ↑, increased; ARI, aripiprazole; CLO, clozapine; CUMS, chronic unpredicatable mild stress; LTDE, long-term dexamethasone exposure; LysoPC, lysophosphatidylcholine; NC, normal control; ns, not significant; PE, phosphatidylethanolamine; RIS, risperidone; UPLC–MS/MS, ultraperformance liquid chromatography-tandem mass spectrometry.
Metabolites responding to atypical antipsychotics are bolded.
Nonparametric Kruskal–Wallis one-way analysis of variance followed by pairwise multiple comparisons.